Neuregulin 1β enhances pulmonary vein arrhythmogenesis by modulating electrophysiological characteristics, calcium and sodium homeostasis via the AKT/CaMKII pathway.
{"title":"Neuregulin 1β enhances pulmonary vein arrhythmogenesis by modulating electrophysiological characteristics, calcium and sodium homeostasis via the AKT/CaMKII pathway.","authors":"Yao-Chang Chen, Wei-Shiang Lin, Shih-Yu Huang, Yen-Yu Lu, Satoshi Higa, Shih-Ann Chen, Yi-Jen Chen","doi":"10.1111/eci.70084","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice and the pulmonary vein (PV) is the most important AF trigger. Neuregulin 1β (NRG1β), which is elevated in patients with paroxysmal AF, may activate signalling pathways that mediate cellular adaptations and subsequent stress in the myocardium. The objectives of this study were to study the effects of NRG1β on the PVs and explore the underlying mechanisms.</p><p><strong>Methods: </strong>A conventional microelectrode, a whole-cell patch clamp, Western blotting and immunofluorescent confocal microscopy were used to investigate electrical activity, calcium (Ca<sup>2+</sup>) regulation, protein expression, ionic currents, reactive oxygen species and cytosolic sodium ([Na<sup>+</sup>]<sub>i</sub>) in isolated rabbit PV tissue and single cardiomyocytes with or without NRG1β (10 nM) incubation for 4 h.</p><p><strong>Results: </strong>NRG1β-treated PVs had faster beating rates and a higher incidence of triggered activity than control PVs. The increased PV spontaneous beating rate induced by NRG1β could be mitigated by ranolazine (a late Na<sup>+</sup> current inhibitor, 10 μM), KN93 (1 μM) and AIP (1 μΜ) (CaMKII inhibitors) and AKTi (AKT-1/2 inhibitor, 10 μM). NRG1β-treated PV cardiomyocytes demonstrated larger late Na<sup>+</sup> and Na<sup>+</sup>-Ca<sup>2+</sup> exchanger current than control PV cardiomyocytes. AIP decreased late Na<sup>+</sup> current in NRG1β-treated PV cardiomyocytes. Furthermore, NRG1β-treated PV cardiomyocytes had smaller intracellular Ca<sup>2+</sup> transients and reduced sarcoplasmic reticulum Ca<sup>2+</sup> contents, but higher levels of [Na<sup>+</sup>]<sub>i</sub>, oxidative stress and RyR-dependent SR Ca<sup>2+</sup> leak than control PV cardiomyocytes. The increased RyR-dependent SR Ca<sup>2+</sup> leak by NRG1β could be alleviated by KN93. Additionally, NRG1β-treated PV cardiomyocytes exhibited upregulated AKT, pAKT, ERK, pERK, CaMKII and pCaMKII, while SERCA2a and PLB were downregulated. AKTi can downregulate oxi-CaMKII and CaMKII in NRG1β-treated PV cardiomyocytes.</p><p><strong>Conclusion: </strong>By modulating electrophysiological characteristics, Ca<sup>2+</sup> homeostasis, and enhancing oxidative stress through AKT/CaMKII signalling, NRG1β increased PV arrhythmogenesis with increasing RyR-dependent SR Ca<sup>2+</sup> leak of PV cardiomyocytes.</p>","PeriodicalId":12013,"journal":{"name":"European Journal of Clinical Investigation","volume":" ","pages":"e70084"},"PeriodicalIF":4.4000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/eci.70084","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice and the pulmonary vein (PV) is the most important AF trigger. Neuregulin 1β (NRG1β), which is elevated in patients with paroxysmal AF, may activate signalling pathways that mediate cellular adaptations and subsequent stress in the myocardium. The objectives of this study were to study the effects of NRG1β on the PVs and explore the underlying mechanisms.
Methods: A conventional microelectrode, a whole-cell patch clamp, Western blotting and immunofluorescent confocal microscopy were used to investigate electrical activity, calcium (Ca2+) regulation, protein expression, ionic currents, reactive oxygen species and cytosolic sodium ([Na+]i) in isolated rabbit PV tissue and single cardiomyocytes with or without NRG1β (10 nM) incubation for 4 h.
Results: NRG1β-treated PVs had faster beating rates and a higher incidence of triggered activity than control PVs. The increased PV spontaneous beating rate induced by NRG1β could be mitigated by ranolazine (a late Na+ current inhibitor, 10 μM), KN93 (1 μM) and AIP (1 μΜ) (CaMKII inhibitors) and AKTi (AKT-1/2 inhibitor, 10 μM). NRG1β-treated PV cardiomyocytes demonstrated larger late Na+ and Na+-Ca2+ exchanger current than control PV cardiomyocytes. AIP decreased late Na+ current in NRG1β-treated PV cardiomyocytes. Furthermore, NRG1β-treated PV cardiomyocytes had smaller intracellular Ca2+ transients and reduced sarcoplasmic reticulum Ca2+ contents, but higher levels of [Na+]i, oxidative stress and RyR-dependent SR Ca2+ leak than control PV cardiomyocytes. The increased RyR-dependent SR Ca2+ leak by NRG1β could be alleviated by KN93. Additionally, NRG1β-treated PV cardiomyocytes exhibited upregulated AKT, pAKT, ERK, pERK, CaMKII and pCaMKII, while SERCA2a and PLB were downregulated. AKTi can downregulate oxi-CaMKII and CaMKII in NRG1β-treated PV cardiomyocytes.
Conclusion: By modulating electrophysiological characteristics, Ca2+ homeostasis, and enhancing oxidative stress through AKT/CaMKII signalling, NRG1β increased PV arrhythmogenesis with increasing RyR-dependent SR Ca2+ leak of PV cardiomyocytes.
期刊介绍:
EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.